Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.
- NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_assertion description "[The multidrug-resistance (MR) status of camptothecin (CPT) was investigated in colon adenocarcinoma HT29 cells, leukemia K562, and breast carcinoma MCF7 cells expressing P-glycoprotein (Pgp) and/or MR-associated protein (MRP1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.
- NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_assertion evidence source_evidence_literature NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.
- NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_assertion SIO_000772 12115804 NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.
- NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_assertion wasDerivedFrom befree-20140225 NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.
- NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_assertion wasGeneratedBy ECO_0000203 NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP500196.RAzqRA6V5AnW0fsQDeqVpxS39W61jBwWOCUrNGCsLViEU130_provenance.